Drug Database
Back to search

United States· US:83980-030_4064e892-4c7a-46a7-9114-3e2bf466e597

etodolac

A etodolac product containing etodolac, registered in United States by Ipca Laboratories Limited. The same ATC class is registered in 7 of our 19 countries.

ATC M01AB08US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedetodolacATCM01AB08REGISTER NO.US:83980-030_4064e892…PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about etodolacAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Etodolac is registered in 7 of 19 countries.

Countries holding a registration under ATC M01AB08 (etodolac), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose
Search etodolac products by name

Etodolac · ATC M01AB08

7 / 19 countries

  • Denmark
  • Finlandprice
  • Franceprice
  • Japan
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of etodolac costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.43 in France to $0.80 in Switzerland — a ×1.9 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Etodolac · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.80
  • FR France$0.43
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ETODOLAC
Manufacturer
Ipca Laboratories Limited
Country
United States (US)
ATC code
M01AB08
ATC class
Etodolac
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    8398003001
    100 TABLET in 1 BOTTLE (83980-030-01)
  • ndc11
    8398003005
    500 TABLET in 1 BOTTLE (83980-030-05)
  • ndc11
    8398003013
    30 TABLET in 1 BOTTLE (83980-030-13)
  • ndc11
    83980-030-01
  • ndc11
    83980-030-05
  • ndc11
    83980-030-13

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

368 interactions on record for etodolac.

Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check etodolac against other medicinesHow interaction checks work

Etodolac · interactions on record

368 records

  • 57 severe
  • 140 moderate
  • 5 minor
  • 85 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Etodolac in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All etodolac products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Bulgaria · Етодин Форт
  • Denmark · Etodolac "2care4"
  • France · Lodine
  • United Kingdom (Northern Ireland) · Etopan Xl, Lodine Sr
  • Lithuania · Dolait
  • Portugal · Dualgan, Exodolan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f3959a52-653c-421d-953a-09e98142bca1
GET /v1/drugs/f3959a52-653c-421d-953a-09e98142bca1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "500",
  "substance": "ETODOLAC",
  "productndc": "83980-030",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA204729",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about etodolac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console